Kestra Advisory Services »

Crispr Therapeutics shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2024-09-30 $572k 12k 46.98
2024-06-30 $870k 16k 54.01
2024-03-31 $1.1M 16k 68.16
2023-12-31 $714k 11k 62.60
2023-09-30 $256k 5.6k 45.39
2023-06-30 $342k 6.1k 56.14
2023-03-31 $272k 6.0k 45.23
2022-12-31 $255k 6.3k 40.65
2022-09-30 $440k 6.7k 65.30
2022-06-30 $415k 6.8k 60.70
2022-03-31 $340k 5.4k 62.85
2021-12-31 $326k 4.3k 75.67
2021-09-30 $1.4M 13k 111.93
2021-06-30 $2.0M 12k 161.89
2021-03-31 $729k 6.0k 121.89
2020-12-31 $1.7M 11k 161.59